Cargando…

A proteomic analysis of chemoresistance development via sequential treatment with doxorubicin reveals novel players in MCF-7 breast cancer cells

Breast cancer exhibits the highest incidence of all cancer types and is the 2nd leading cause of cancer mortality in women. Up to 82% of breast cancer patients receive a chemotherapy-containing treatment regimen. However, numerous breast tumors recur within 10 years following an initial response and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sommer, Ann-Katrin, Hermawan, Adam, Ljepoja, Bojan, Fröhlich, Thomas, Arnold, Georg J., Wagner, Ernst, Roidl, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108857/ https://www.ncbi.nlm.nih.gov/pubmed/30066829 http://dx.doi.org/10.3892/ijmm.2018.3781

Ejemplares similares

A proteomic analysis of an in vitro knock-out of miR-200c
por: Ljepoja, Bojan, et al.
Publicado: (2018)

Downregulation of GRK5 hampers the migration of breast cancer cells
por: Sommer, Ann-Katrin, et al.
Publicado: (2019)

Salinomycin co-treatment enhances tamoxifen cytotoxicity in luminal A breast tumor cells by facilitating lysosomal degradation of receptor tyrosine kinases
por: Sommer, Ann-Katrin, et al.
Publicado: (2016)

Combating Drug Resistance by Exploiting miRNA-200c-Controlled Phase II Detoxification
por: Köhler, Bianca, et al.
Publicado: (2022)

Inducible microRNA-200c decreases motility of breast cancer cells and reduces filamin A
por: Ljepoja, Bojan, et al.
Publicado: (2019)

miR-200c Sensitizes Breast Cancer Cells to Doxorubicin Treatment by Decreasing TrkB and Bmi1 Expression
por: Kopp, Florian, et al.
Publicado: (2012)

Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
por: Wang, Xu, et al.
Publicado: (2019)

Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration
por: Kopp, Florian, et al.
Publicado: (2014)

Sequential Salinomycin Treatment Results in Resistance Formation through Clonal Selection of Epithelial-Like Tumor Cells()()
por: Kopp, Florian, et al.
Publicado: (2014)

Cholesterol Dependent Uptake and Interaction of Doxorubicin in MCF-7 Breast Cancer Cells
por: Weber, Petra, et al.
Publicado: (2013)

Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
por: Wang, Xu, et al.
Publicado: (2020)

Combination of Ethanolic Extract of Citrus aurantifolia Peels with Doxorubicin Modulate Cell Cycle and Increase Apoptosis Induction on MCF-7 Cells
por: Adina, Anugerah Budipratama, et al.
Publicado: (2014)

Surface Stiffness Has No Impact on MCF-7 Sensitivity to Doxorubicin
por: Šimoliūnas, Egidijus, et al.
Publicado: (2023)

Metabolomic Identification of Anticancer Metabolites of Australian Propolis and Proteomic Elucidation of Its Synergistic Mechanisms with Doxorubicin in the MCF7 Cells
por: Alsherbiny, Muhammad A., et al.
Publicado: (2021)

Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells
por: Srdic-Rajic, Tatjana, et al.
Publicado: (2017)

Combined effect of papuamine and doxorubicin in human breast cancer MCF-7 cells
por: KANNO, SYU-ICHI, et al.
Publicado: (2014)

The Cytotoxic and Antimigratory Activity of Brazilin-Doxorubicin on MCF-7/HER2 Cells
por: Jenie, Riris Istighfari, et al.
Publicado: (2018)

Synergistic Cytotoxicity of Renieramycin M and Doxorubicin in MCF-7 Breast Cancer Cells
por: Tun, Jortan O., et al.
Publicado: (2019)

Discovery of IL-18 As a Novel Secreted Protein Contributing to Doxorubicin Resistance by Comparative Secretome Analysis of MCF-7 and MCF-7/Dox
por: Yao, Ling, et al.
Publicado: (2011)

Rational design of multifunctional micelles against doxorubicin-sensitive and doxorubicin-resistant MCF-7 human breast cancer cells
por: Hong, Wei, et al.
Publicado: (2017)

Proteomic Comparison of MCF-7 Tumoursphere and Monolayer Cultures
por: Morrison, Brian J., et al.
Publicado: (2012)

The proto-oncogene KRAS is targeted by miR-200c
por: Kopp, Florian, et al.
Publicado: (2013)

Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance
por: Bessone, Federica, et al.
Publicado: (2021)

Ligand-specific sequential regulation of transcription factors for differentiation of MCF-7 cells
por: Saeki, Yuko, et al.
Publicado: (2009)

Magnetic nanoparticles sensitize MCF-7 breast cancer cells to doxorubicin-induced apoptosis
por: Aljarrah, Khaled, et al.
Publicado: (2012)

Role of autophagy and lysosomal drug sequestration in acquired resistance to doxorubicin in MCF-7 cells
por: Guo, Baoqing, et al.
Publicado: (2016)

Avoiding the Interference of Doxorubicin with MTT Measurements on the MCF-7 Breast Cancer Cell Line
por: Luis, Carla, et al.
Publicado: (2019)

Author Correction: Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells
por: Srdic-Rajic, Tatjana, et al.
Publicado: (2018)

Rational Design of Multifunctional Micelles Against Doxorubicin-Sensitive and Doxorubicin-Resistant MCF-7 Human Breast Cancer Cells [Retraction]
Publicado: (2022)

Obesity: an heavyweight player in breast cancer’s chemoresistance
por: Vaysse, Charlotte, et al.
Publicado: (2019)

Macrophages and Fibroblasts, Key Players in Cancer Chemoresistance
por: Ireland, Lucy V., et al.
Publicado: (2018)

Proteomic Analysis of Glioma Chemoresistance
por: Suk, Kyoungho
Publicado: (2012)

A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia
por: Zeng, Yunxin, et al.
Publicado: (2021)

Pleiotrophin promotes chemoresistance to doxorubicin in osteosarcoma by upregulating P-glycoprotein
por: Wu, Dapeng, et al.
Publicado: (2017)

A Novel Agent Enhances the Chemotherapeutic Efficacy of Doxorubicin in MCF-7 Breast Cancer Cells
por: Wang, Liang, et al.
Publicado: (2016)

Synergistic combination of doxorubicin with hydralazine, and disulfiram against MCF-7 breast cancer cell line
por: Lafi, Zainab, et al.
Publicado: (2023)

Salinomycin enhances doxorubicin-induced cytotoxicity in multidrug resistant MCF-7/MDR human breast cancer cells via decreased efflux of doxorubicin
por: KIM, KWANG-YOUN, et al.
Publicado: (2015)

Insulin stimulated MCF7 breast cancer cells: Proteome dataset
por: Sarvaiya, Hetal A., et al.
Publicado: (2016)

Knockdown of SALL4 inhibits the proliferation and reverses the resistance of MCF-7/ADR cells to doxorubicin hydrochloride
por: Chen, Yuan-Yuan, et al.
Publicado: (2016)

Combinatorial Cytotoxic Effects of Damnacanthal and Doxorubicin against Human Breast Cancer MCF-7 Cells in Vitro
por: Aziz, Muhammad Yusran Abdul, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2jvo4i10un274u2jius9u7h6vn